Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Other Operating Expenses (2022 - 2025)

Cannabis Bioscience International Holdings' Other Operating Expenses history spans 4 years, with the latest figure at $96270.0 for Q4 2025.

  • For Q4 2025, Other Operating Expenses rose 42.82% year-over-year to $96270.0; the TTM value through Nov 2025 reached $413237.0, down 4.02%, while the annual FY2025 figure was $516557.0, 8.33% up from the prior year.
  • Other Operating Expenses for Q4 2025 was $96270.0 at Cannabis Bioscience International Holdings, up from $56261.0 in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $257551.0 in Q4 2022 and bottomed at $33259.0 in Q2 2024.
  • The 4-year median for Other Operating Expenses is $123943.0 (2023), against an average of $132666.9.
  • The largest annual shift saw Other Operating Expenses tumbled 84.47% in 2024 before it surged 500.12% in 2025.
  • A 4-year view of Other Operating Expenses shows it stood at $257551.0 in 2022, then plummeted by 58.66% to $106468.0 in 2023, then tumbled by 36.69% to $67408.0 in 2024, then skyrocketed by 42.82% to $96270.0 in 2025.
  • Per Business Quant, the three most recent readings for CBIH's Other Operating Expenses are $96270.0 (Q4 2025), $56261.0 (Q3 2025), and $199594.0 (Q2 2025).